ARTICLE | Clinical News
DynaGraft II regulatory update
April 11, 2005 7:00 AM UTC
FDA granted 510(k) clearance for ISON's DynaGraft II product family for orthopedic applications. The bone graft substitute is derived from demineralized bone matrix (DBM) and is delivered via a revers...